The South African Tuberculosis Vaccine Initiative (SATVI) is a tuberculosis research group with a research focus that spans several disciplines including paediatrics, infectious diseases, epidemiology, public health, immunology, systems biology and clinical sciences. SATVI has a large and well-developed clinical field site in the Boland Overberg region, with the core on the premises of the Brewelskloof TB Hospital in Worcester, from where most clinical/epidemiological studies and clinical trials of new TB vaccines are conducted. The Immunology and Laboratory based work is led by Associate Professor Tom Scriba; and the Clinical Trials work is led by SATVI Director, Associate Professor Mark Hatherill.
View Top Employees from South African Tuberculosis Vaccine Initiative (SATVI)| Website | http://www.satvi.uct.ac.za |
| Employees | 60 (32 on RocketReach) |
| Founded | 2001 |
| Industry | Research Services |
| Web Rank | 10807 |
| Web Visits | 5 Million |
| Keywords | Uct Exam Timetable, Peoplesoft Uct, Vula, Myuct, Jammie Schedule, Uct Gsb Short Courses, Gsb Uct, Contract Management Courses In South Africa |
Looking for a particular South African Tuberculosis Vaccine Initiative (SATVI) employee's phone or email?
South African Tuberculosis Vaccine Initiative (SATVI) Questions
32 people are employed at South African Tuberculosis Vaccine Initiative (SATVI).
South African Tuberculosis Vaccine Initiative (SATVI) is based in Cape Town, Western Cape.
Top South African Tuberculosis Vaccine Initiative (SATVI) Employees
Related Companies
